For the Inventor, By the Inventor

Enter assignee name

New Haven, CT, United States of America

Melinta Therapeutics, Inc.

USPTO Granted Patents = 23

CIPO Patents = 4

EPO Patents = 18

Trademarks = 16

Forward Citations = 54

Loading Chart...

Loading Chart...

50 inventors (with patents filed for the assignee):

Ashoke Bhattacharjee (13 out of 34 patents)

Erin M Duffy (8 out of 22 patents)

Shili Chen (8 out of 31 patents)

4. Rongliang Lou (8 out of 19 patents)

5. Zoltan F Kanyo (7 out of 19 patents)

6. Hardwin O'Dowd (6 out of 17 patents)

7. Roger Hanselmann (6 out of 14 patents)

8. Brian T Wimberly (6 out of 6 patents)

9. Yusheng Wu (6 out of 14 patents)

10. Marco DeVivo (5 out of 5 patents)

11. Jiacheng Zhou (4 out of 85 patents)

12. Yanming Du (3 out of 11 patents)

13. Adel Rafai Far (3 out of 13 patents)

14. Sandra Sinishtaj (3 out of 3 patents)

15. Yuanqing Tang (3 out of 3 patents)

23 patents: Sort by Forward Citations

1. 10864249 - High purity oritavancin and method of producing same (2020-12-15),

2. 10328118 - High purity oritavancin and method of producing same (2019-06-25),

3. 10259825 - Antimicrobial compounds and methods of making and using the same (2019-04-16),

4. 10201587 - Methods of inhibiting and treating biofilms using glycopeptide antibiotics (2019-02-12),

5. 10106543 - Antimicrobial compounds and methods of making and using the same (2018-10-23),

6. 9937183 - Antimicrobial compounds and methods of making and using the same (2018-04-10),

7. 9845297 - Antimicrobial compounds and methods of making and using the same (2017-12-19),

8. RE46617 - Process for making quinolone compounds (2017-11-27),

9. 9573962 - Antimicrobial compounds and methods of making and using the same (2017-02-21),

10. 9550783 - Biaryl heterocyclic compounds and methods of making and using the same (2017-01-24),

11. 9409896 - Sustained release pharmaceutical compositions comprising an antibacterial agent (2016-08-09),

12. 9376400 - Process for the synthesis of triazoles (2016-06-28),

13. 9221827 - Antimicrobial compounds and methods of making and using the same (2015-12-29),

14. 9216979 - Antimicrobial compounds and methods of making and using the same (2015-12-22),

15. 9193731 - Antimicrobial compounds and methods of making and using the same (2015-11-24),

Melinta Therapeutics is a commercial-stage pharmaceutical company focused on the development and commercialization of novel antibiotics to treat various infectious diseases. With a diverse portfolio of antibiotics, Melinta aims to address the growing global threat of antibiotic resistance. The company's mission is to provide innovative solutions to improve patient outcomes and advance public health. For more information about Melinta Therapeutics, please visit their website.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

23 Patents

#13 in New Haven, CT

#321 in Connecticut

#13,951 in US

#26,825 in the World

New Haven, CT, United States of America

Melinta Therapeutics, Inc.

Forward Citations = 54

50 inventors:

Ashoke Bhattacharjee (13 out of 34 patents)

Erin M Duffy (8 out of 22 patents)

Shili Chen (8 out of 31 patents)

4. Rongliang Lou (8 out of 19 patents)

5. Zoltan F Kanyo (7 out of 19 patents)

Please report any incorrect information to support@idiyas.com

Loading…